Cargando…
How Should We Measure and Deal with Office Blood Pressure in 2021?
Arterial hypertension is a major risk factor for cardiovascular disease worldwide. Office blood pressure measurements (OBPMs) are still recommended for diagnosis and follow-up by all major guidelines; however, the recommended procedures differ significantly. In analogy, major outcome studies usually...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913758/ https://www.ncbi.nlm.nih.gov/pubmed/33546474 http://dx.doi.org/10.3390/diagnostics11020235 |
_version_ | 1783656876316033024 |
---|---|
author | Vischer, Annina S. Burkard, Thilo |
author_facet | Vischer, Annina S. Burkard, Thilo |
author_sort | Vischer, Annina S. |
collection | PubMed |
description | Arterial hypertension is a major risk factor for cardiovascular disease worldwide. Office blood pressure measurements (OBPMs) are still recommended for diagnosis and follow-up by all major guidelines; however, the recommended procedures differ significantly. In analogy, major outcome studies usually apply OBPMs, again, with a variety of procedures. This variety of OBPM procedures complicates the comparability between studies and challenges daily clinical practice. In this narrative review, we compile the most recent recommendations for office blood pressure measurement together with the major limitations and strategies and how these could be overcome. |
format | Online Article Text |
id | pubmed-7913758 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79137582021-02-28 How Should We Measure and Deal with Office Blood Pressure in 2021? Vischer, Annina S. Burkard, Thilo Diagnostics (Basel) Review Arterial hypertension is a major risk factor for cardiovascular disease worldwide. Office blood pressure measurements (OBPMs) are still recommended for diagnosis and follow-up by all major guidelines; however, the recommended procedures differ significantly. In analogy, major outcome studies usually apply OBPMs, again, with a variety of procedures. This variety of OBPM procedures complicates the comparability between studies and challenges daily clinical practice. In this narrative review, we compile the most recent recommendations for office blood pressure measurement together with the major limitations and strategies and how these could be overcome. MDPI 2021-02-03 /pmc/articles/PMC7913758/ /pubmed/33546474 http://dx.doi.org/10.3390/diagnostics11020235 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Vischer, Annina S. Burkard, Thilo How Should We Measure and Deal with Office Blood Pressure in 2021? |
title | How Should We Measure and Deal with Office Blood Pressure in 2021? |
title_full | How Should We Measure and Deal with Office Blood Pressure in 2021? |
title_fullStr | How Should We Measure and Deal with Office Blood Pressure in 2021? |
title_full_unstemmed | How Should We Measure and Deal with Office Blood Pressure in 2021? |
title_short | How Should We Measure and Deal with Office Blood Pressure in 2021? |
title_sort | how should we measure and deal with office blood pressure in 2021? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913758/ https://www.ncbi.nlm.nih.gov/pubmed/33546474 http://dx.doi.org/10.3390/diagnostics11020235 |
work_keys_str_mv | AT vischeranninas howshouldwemeasureanddealwithofficebloodpressurein2021 AT burkardthilo howshouldwemeasureanddealwithofficebloodpressurein2021 |